Literature DB >> 15874973

Cocaine- and amphetamine-regulated transcript (CART) peptide: a vasoactive role in the cerebral circulation.

Jeffrey J Iliff1, Nabil J Alkayed, Kiarash J Gloshani, Richard J Traystman, G Alexander West.   

Abstract

Cocaine- and amphetamine-regulated transcript (CART) peptides are known to be involved in the stress response and have been implicated in the regulation of the cardiovascular system. We evaluated the direct vasoactive properties of CART in the cerebral circulation and its potential mechanisms of action. Penetrating cerebral arterioles, isolated from male Sprague-Dawley rats, were cannulated using a concentric micropipette setup, pressurized and perfused. The vascular response to intraluminal and extraluminal CART peptide was characterized. The endothelium dependence of this response was assessed by means of the endothelial light-dye injury model. The nonspecific endothelin receptor antagonist PD-145065, the ET(A)-specific antagonist BQ-123, the ET(B)-specific antagonist BQ-788, and the inhibitor of endothelin-converting enzyme phosphoramidon were used to characterize the involvement of the endothelin pathway in the vascular response to CART peptide. Extraluminal and intraluminal application of CART peptide (0.1 nm to 1 micromol/L) evoked a long-lasting dose-dependent constriction of isolated penetrating cerebral arterioles to approximately 80% of resting myogenic tone. Disruption of the endothelium by the endothelial light/dye injury model resulted in the abolition of this response (P<0.05). Extraluminal administration of PD-145065, BQ-123, and phosphoramidon blocked the constriction response to CART peptide (P<0.01). The ET(B) antagonist, BQ-788, did not alter the constriction response to CART peptide. Cocaine- and amphetamine-regulated transcript peptide is a potent vasoconstrictor in the cerebral circulation. Its direct vasoactive properties are endothelium-dependent and are mediated by ET(A), not ET(B), endothelin receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15874973     DOI: 10.1038/sj.jcbfm.9600136

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  7 in total

1.  Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotection.

Authors:  Yun Xu; Wenri Zhang; Judith Klaus; Jennifer Young; Ines Koerner; Laird C Sheldahl; Patricia D Hurn; Francisco Martínez-Murillo; Nabil J Alkayed
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-13       Impact factor: 11.205

Review 2.  CART peptides: regulators of body weight, reward and other functions.

Authors:  G Rogge; D Jones; G W Hubert; Y Lin; M J Kuhar
Journal:  Nat Rev Neurosci       Date:  2008-10       Impact factor: 34.870

3.  Aqueous humor proteomic analysis of acute angle-closure glaucoma with visual field loss.

Authors:  Jiyu Xu; Liangliang Zhao; Xiang Liu; Haidan Sun; Xiaoyan Liu; Zhengguang Guo; Ying Wang; Wei Sun
Journal:  Ann Transl Med       Date:  2021-11

4.  Endocrine Disruptor Bisphenol a Affects the Neurochemical Profile of Nerve Fibers in the Aortic Arch Wall in the Domestic Pig.

Authors:  Liliana Rytel; László Könyves; Slawomir Gonkowski
Journal:  Int J Environ Res Public Health       Date:  2022-05-13       Impact factor: 4.614

Review 5.  CART peptides as modulators of dopamine and psychostimulants and interactions with the mesolimbic dopaminergic system.

Authors:  George W Hubert; Douglas C Jones; Mark C Moffett; George Rogge; Michael J Kuhar
Journal:  Biochem Pharmacol       Date:  2007-07-26       Impact factor: 5.858

6.  In vivo cerebrovascular effects of cocaine- and amphetamine-regulated transcript (CART) peptide.

Authors:  Jeffrey J Iliff; Nabil J Alkayed; Kiarash J Golshani; Jason Weinstein; Richard J Traystman; G Alexander West
Journal:  J Cardiovasc Pharmacol       Date:  2008-07       Impact factor: 3.105

7.  Quantitative evaluation of CART-containing cells in urinary bladder of rats with renovascular hypertension.

Authors:  I Janiuk; I Kasacka
Journal:  Eur J Histochem       Date:  2015-04-13       Impact factor: 3.188

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.